Apr19Tue

News from Amicus Therapeutics

News from a former Ambassador Award Honoree: Amicus Therapeutics Announces Issuance of New U.S. Composition of Matter Patent for Galafold® (migalastat), Strengthening Patent Protection Through 2038

Galafold U.S. Intellectual Property Protection Now Includes 35 Issued Patents, 18 of which expire in 2038

PHILADELPHIA, April 19, 2022 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for rare diseases, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,304,940, which is directed to a composition of matter covering migalastat (Galafold®).

The new U.S. patent titled “Methods of Treating Fabry Patients Having Renal Impairments” is directed to a molecule comprising migalastat bound to an alpha-galactosidase A protein and expires in 2038.

Read More

Apr13Wed

Member News from Acumen Analytics

Acumen Analytics Launches ‘Life Sphere’ A New Podcast Dedicated to the People in Life Sciences.

The podcast features experts and advocates discussing trends, tools, careers and all components of the Life Sciences industry.

The first episodes of season one will be available May 3. New episodes will be released on Tuesdays. To learn more about Life Sphere, check the Acumen website for more details as they become available https://acumenanalytics.com/news/

Nov17Wed

Member News: Jefferson & Bayada Joint Venture

Jefferson Health and Bayada to take ‘revolutionary step’ in home care with new joint venture
Philadelphia Business Journal 

Jefferson Health and Bayada Home Health Care entered into a definitive agreement Tuesday to form a joint venture that will accelerate the transformation of post-acute care and digital health.

The joint venture, tentatively called “Jefferson Health at Home,” will serve Jefferson home care patients in New Jersey and Pennsylvania.

Read More

Oct20Wed

Former Taoiseach Award publishes book in US & Canada

Congratulations to our 2018 Taoiseach Award honoree, Jerry Maginnis, on the publication of his book “Advice for a Successful Career in the Accounting Profession. How to Make Your Assets Greatly Exceed Your Liabilities”, which was released nationally in the US and Canada by the publisher, Wiley.

This short article that provides more color on the topics addressed in the book: https://mydigitalpublication.com/publication/?i=720910&ver=html5&p=52

The book is available on Amazon and will also be carried in retail locations nationally, including selected Barnes & Noble stores.

Sep29Wed

Philadelphia Life Sciences News

News from a former Ambassador Award honoree John F. Crowley: Amicus Therapeutics and ARYA Sciences Acquisition Corp IV Announce Formation of a Next-Generation Genetic Medicine Company: “Caritas Therapeutics”

“This is a big, bold vision and a massive step forward for next generation biotechnologies for people worldwide living with some of the most devastating rare diseases. In a single stroke with the formation and funding of Caritas we will create what will be one of the world’s preeminent next-generation genetic medicines companies. “ John Crowley, Chairman, CEO and president, Amicus Therapeutics, as the lead.

Click HERE to read more.